XML 100 R85.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule of Quarterly Financial Information (Details) (Parenthetical) - USD ($)
 3 Months Ended 12 Months Ended 19 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2020
Quarterly Financial Information Disclosure [Abstract]                                
Asset impairment charge $ 1,400,000 $ 982,000 $ 8,200,000           $ 4,000,000.0   $ 1,600,000   $ 10,600,000 $ 6,000,000.0 $ 5,600,000 $ 10,600,000
Valuation allowance $ 1,300,000                       1,300,000     $ 1,300,000
Effective Income Tax Rate Reconciliation, Percent 36.30% (20.50%) (28.90%) 22.00% (371.70%) 24.10% 22.30% 8.40% 103.80% 25.30% 24.20% (134.30%)        
Net gain on sale of business and assets                           2,900,000    
Gain on sale of business and assets         $ 400,000 $ 300,000 $ 1,100,000 $ 1,200,000         777,000 2,966,000 (2,162,000)  
Net gain loss on insurance                           800,000    
Gain (Loss) Related to Litigation Settlement         $ 900,000 $ 100,000         $ 1,600,000   (596,000) 288,000 20,000  
Deferred Income Tax Expense (Benefit)                       $ 8,800,000 $ (1,268,000) $ 821,000 $ (6,775,000)  
Deferred income tax benefit, gross                       $ 9,700,000        
Deferred tax expense                 $ 827,000   $ 38,000